EVOLUTE® HYDRO Solid Phase Extraction plates gives customers the ability to perform sample (typically urine) hydrolysis within the wells of the extraction plate, followed directly by sample clean up using solid phase extraction, without the need for sample transfer. The Hydro frit technology used by the plates reliably “holds up” both sample and enzyme during incubation at elevated temperatures. This reduces clogging during subsequent clean up steps, leading to robust and streamlined sample preparation. Sample clean-up is performed in the same plate, without the need to transfer samples, saving time and reducing risky sample handling steps.
The plates are packed with high quality 30 µm EVOLUTE® media, with CX (mixed mode strong cation exchange) and ABN (wettable/non-polar) phases available at launch. EVOLUTE® HYDRO can be processed using 96-well compatible positive pressure manifolds (e.g. Biotage® Pressure+ 96), vacuum manifolds (e.g. Biotage® VacMaster™ 96) and automated liquid handling systems (e.g. Biotage® Extrahera™).
“By combining our unique Hydro frit technology with our wettable EVOLUTE® sorbents, the new SPE plates allow the hydrolyzed sample to be loaded directly onto the SPE bed for clean-up. The conditioning and equilibration steps are eliminated, saving time and reducing costs.” said Dr. Claire Desbrow, Global Product Manager, Analytical Chemistry, Biotage.
For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 3 5627 3123, other areas please call +46 18 56 57 10.
For further press information from Biotage please contact: James Churchill, Marketing Communications Manager, Biotage GB Ltd. Distribution Way, Dyffryn Business Park, Ystrad Mynach, Hengoed, Wales CF82 7TS United Kingdom. Tel: +44 (0)1443 811 849. Mobile: +44 (0) 7875 484778. Email: email@example.com
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in South Korea, China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 308 employees, with sales of 667 MSEK in 2016. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com
White Paper from Biotage: Practical Considerations Using Quantisal® Oral Fluid Collection Devices
New UV Monitor Kit for Large Scale Purification
Peptide Workflow by Biotage
Thank you for visiting our Analytica Booth
Application Video: Extraction Steroids from Serum with ISOLUTE® SLE+